Skip to content

VALN

Valneva SE

NASDAQ · Healthcare · Biotechnology · FR

$6.56
−0.15%
Ask drillr

Margins

Gross margin
16.4%
EBITDA margin
-65.7%
EBIT margin
-80.9%
Net margin
-110.2%
FCF margin
-59.7%
-195.1%
Return on equity
-40.8%
Return on assets
-39.9%
Return on invested capital
0.38x
Asset turnover
-$95.4M
Cash from operations
$1.47
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026